Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
1.48
-0.06 (-3.90%)
At close: Aug 18, 2025, 2:56 PM
Cognition Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.73 | -0.77 | -1.04 | -0.48 | -2.38 | -1.75 | -1.75 | -1.62 | -2.87 | -4.26 | 1.39 | -17.5 | -2.07 | -4.02 | -4.51 | -21.51 | -44.89 | 305.96 |
PEG Ratio | 0.03 | 0.04 | 0.03 | -0.01 | 0.07 | -0.46 | -0.1 | -0.04 | -0.09 | 0.03 | -0.00 | 0.20 | -0.04 | 0.08 | -0.03 | -0.19 | 0.06 | -2.74 |
PS Ratio | n/a | n/a | 130.25 | n/a | n/a | n/a | 153.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.81 | 2.12 | 1.74 | 1.31 | 2.91 | 2.22 | 2.33 | 1.51 | 1.58 | 1.61 | 1.51 | 1.11 | 1.09 | 1.27 | 2.58 | -3.09 | -3.2 | -4.02 |
P/FCF Ratio | -3.51 | -2.63 | -3.88 | -2.76 | -11.15 | -8.85 | -10.38 | -10.36 | -14.59 | -20.98 | -5.97 | -1.62K | -8.89 | -19.75 | 1.79K | -130.52 | -294.04 | -353.51 |
P/OCF Ratio | -3.51 | -2.63 | -3.88 | -2.76 | -11.16 | -8.85 | -10.44 | -10.51 | -14.66 | -21.3 | -5.98 | -10.94K | -8.9 | -20.64 | 1.31K | -130.52 | -294.04 | -353.51 |
OCF/S Ratio | n/a | n/a | -33.53 | n/a | n/a | n/a | -14.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | 0.03 | n/a | -0.98 | -1.01 | -0.19 |
Quick Ratio | 1.54 | 2.09 | 2.65 | 2.11 | 3.07 | 4.00 | 3.37 | 4.38 | 5.25 | 5.73 | 6.11 | 4.20 | 7.93 | 7.38 | 7.73 | 2.14 | 2.24 | 3.62 |
Current Ratio | 1.54 | 2.09 | 2.65 | 2.11 | 3.07 | 4.00 | 3.37 | 4.38 | 5.25 | 5.73 | 6.11 | 4.20 | 7.44 | 7.38 | 7.50 | 2.27 | 2.36 | 3.68 |
Asset Turnover | n/a | n/a | 0.01 | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -4.66K | 2.75K | -2.14K | -4.82K | -2.1K | -1.41K | -1.69K | -7.37K | -1.97K | -897.3 | -930 | -6.31K | -1.74K | -1.05K | n/a | n/a | -16.76 | -10.4 |
Return on Equity | -0.96 | -0.69 | -0.42 | -0.69 | -0.31 | -0.32 | -0.33 | -0.23 | -0.14 | -0.09 | 0.27 | -0.02 | -0.13 | -0.08 | -0.14 | 0.04 | 0.02 | n/a |
Return on Assets | -0.34 | -0.36 | -0.26 | -0.36 | -0.2 | -0.24 | -0.23 | -0.17 | -0.11 | -0.07 | 0.22 | -0.01 | -0.11 | -0.07 | -0.12 | -0.23 | -0.09 | 0.01 |
Return on Invested Capital | -1.87 | -1.07 | -0.55 | -0.95 | -0.62 | -0.47 | -0.59 | -0.48 | -0.32 | -0.13 | 0.46 | -0.03 | -0.26 | -0.19 | -0.23 | -0.58 | -0.54 | -0.46 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | -0.28 | n/a | n/a | n/a | 0.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -31.37 | n/a | n/a | n/a | -21.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -31.37 | n/a | n/a | n/a | -21.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -42.89 | n/a | n/a | n/a | -40.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -31.06 | n/a | n/a | n/a | -21.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |